Sofpromed
Private Company
Funding information not available
Overview
Sofpromed is a privately held, revenue-generating service provider in the clinical research sector, operating as a full-service CRO. It assists biotech companies in executing global clinical trials from Phase I through IV, with a broad therapeutic focus led by oncology. The company has established operational hubs in North America, the UK, Europe, and Asia-Pacific, positioning itself as a mid-sized, globally capable partner for emerging biotechs.
Technology Platform
Integrated full-service clinical trial management platform encompassing regulatory affairs, site management, monitoring, data management, pharmacovigilance, biostatistics, medical writing, and project management. Leverages a global operational footprint with local offices in key regions (US, UK, EU).
Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive global CRO market, competing against large public players (e.g., IQVIA, ICON, Labcorp) with vast resources and extensive scale, as well as numerous small-to-mid-sized private CROs specializing in specific regions or therapeutic areas. Differentiation is based on personalized service, oncology expertise, and a full-service model tailored for biotech clients.